Founder Team
Founder and teams are with interdisplinary background of pharmacology, chemistry, physics, computer science, bioinformatics, medical science
Founder and teams are with interdisplinary background of pharmacology, chemistry, physics, computer science, bioinformatics, medical science
Beijing Gigaceuticals Tech Co., Ltd. is a novel drug development company driven by the novel artificial intelligence, owing the target independent, deep learning and gene signatures based DLEPS system. Pipelines cover aging, obesity, hyperuricemia, NASH, cancer and etc. For instance, the longevity extension compound is able to extend lifespan of mice by 145 days.
Founder, CEO, Experts in AI, systems biology and pharmacology.
Drug Development for Metabolic Diseases
application programmers, model development
Medicinal chemical synthesis, virtual screening of medicinal chemistry, etc.
Skin anti-aging research
Ph.D., Assistant Professor, Peking University Health science center.
Discipline area: Cardiovascular and membrane channel pharmacology.
Research Profiles:
Majored in development of drugs for the prevention and treatment of hypertension, diabetic vascular disease, cerebral ischemia, renal ischemia reperfusion injury and polycystic kidney disease.
Peking University School of Stomatology, investigator, PHD Supervisor.
Discipline area: Biomimetic nanomaterials and dental hard tissue regeneration.
Research Profiles:
1) Biomineralization;
2) Biomimetic nanomaterials and tissue engineering;
3) Stem cells and tissue repair;
4) Tooth movement and fibril remodeling;
5) Dentin bonding
Peking University, researcher.
Research Profiles:
Neurometabolism (PKA participates in the neural and molecular mechanisms of metabolic diseases);
Neuroscience (Research on brain nerve pathways, molecular anatomy and dopamine receptor neurons);
Stem cell and regenerative medicine (Research on cardiovascular regenerative medicine).
